Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Neurology & psychiatryPRM 0055
Dosage formTablets
Oral

Aceclofenac 100 mg, Tizanidine 2 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Class II
Drugs Rules status
Schedule HList or category match
CDSCO categoryFDC
Documented match

Listed in CDSCO FDC approval records

CDSCO filing reference · page 549
Neurology & psychiatryPRM 0058
Dosage formTablets
Oral

Aceclofenac 200 mg (SR), Calcitriol 0.25 mcg, Calcium Citrate 1000 mg, Pregabalin 75 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Drugs Rules status
H caution · H1 pendingH1 not yet in force
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0059
Dosage formTablets
Oral

Aceclofenac 200 mg (SR), Pregabalin 75 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
H caution · H1 pendingH1 not yet in force
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 491
Neurology & psychiatryPRM 2625
Dosage formTablets
Oral

Adenosylcobalamin 750 mcg, Methylcobalamin 750 mcg, Pregabalin 75 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gabapentinoid + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2631
Dosage formTablets
Oral

Agomelatine 25 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Other antidepressant
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2658
Dosage formTablets
Oral

Almotriptan 12.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Triptan antimigraine agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2659
Dosage formTablets
Oral

Almotriptan 6.25 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Triptan antimigraine agent
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2667
Dosage formTablets
Oral

Alpha Glycerylphosphorylcholine 250 mg, Piracetam 800 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Cognitive-support / nootropic agent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 4648
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 0.5 mg, Methylcobalamin 750 mcg, Pregabalin 75 mg (ER), Pyridoxine Hcl 1.5 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gabapentinoid + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2169
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 750 mcg, Pregabalin 150 mg, Pyridoxine 1.5 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Neuropathic pain agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Drugs Rules status
H caution · H1 pendingH1 not yet in force
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 4653
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 750 mcg, Pregabalin 150 mg, Pyridoxine 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gabapentinoid + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 4654
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 750 mcg, Pregabalin 75 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gabapentinoid + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2170
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 1.5 mg, Methylcobalamin 750 mcg, Pregabalin 75 mg, Pyridoxine 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Neuropathic pain agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Drugs Rules status
H caution · H1 pendingH1 not yet in force
CDSCO categoryFDC
Documented match

Listed in CDSCO FDC approval records

CDSCO filing reference · page 561
Neurology & psychiatryPRM 2168
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folic Acid 5 mg, Magnesium 50 mg, Methylcobalamin 1500 mcg, Pregabalin 150 mg, Pyridoxine 3 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Neuropathic pain agent
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Drugs Rules status
H caution · H1 pendingH1 not yet in force
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 4657
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Folicacid 1.5 mg, Methylcobalamin 750 mcg, Pregabalin 75 mg, Pyridoxine Hcl 1.5 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gabapentinoid + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0096
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Gabapentin 100 mg, Methylcobalamin 500 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Neuropathic pain agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 467
Neurology & psychiatryPRM 0097
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Gabapentin 300 mg, Methylcobalamin 500 mcg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Neuropathic pain agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
CDSCO categoryFDC
Documented match

FDC Category C continued-manufacture listing

CDSCO filing reference · page 467
Neurology & psychiatryPRM 0098
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Gabapentin 300 mg, Methylcobalamin 750 mcg, Pyridoxine 3 mg Film Coated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Neuropathic pain agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 2678
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, L-Methyl Folate 1 mg, Methylcobalamin 1500 mcg, Pregabalin 150 mg, Pyridoxal -5-Phosphate 1.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Gabapentinoid + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0099
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, L-Methyl Folate Calcium 1 mg, Methylcobalamin 1500 mcg, Pregabalin 75 mg, Pyridoxal 5-Phosphate 1.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Neuropathic pain agent
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Drugs Rules status
H caution · H1 pendingH1 not yet in force
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 4659
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Methylcobalamin 0.75 mg, Pregabalin 75 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gabapentinoid + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 0100
Dosage formTablets
Oral

Alpha Lipoic Acid 100 mg, Methylcobalamin 1500 mcg, Pregabalin 75 mg, Pyridoxine 3 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Neuropathic pain agent
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Drugs Rules status
H caution · H1 pendingH1 not yet in force
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 4660
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 100 mg, Methylcobalamin 750 mcg, Pregabalin 75 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gabapentinoid + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Neurology & psychiatryPRM 4668
Dosage formHard-gelatin capsules
Oral

Alpha Lipoic Acid 300 mg, L-Methylfolate 0.5 mg, Methylcobalamin 750 mcg, Pregabalin 75 mg, Pyridoxal 5 Phosphate 10 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Gabapentinoid + Antioxidant / nutritional supplement + Vitamin / mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product